-
3
-
-
0032584250
-
Elevated circulating levels of C-C chemokines in patients with congestive heart failure
-
Aukrust P, Ueland T, Muller F, et al. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation. 1998;97:1136-43. (Pubitemid 28152886)
-
(1998)
Circulation
, vol.97
, Issue.12
, pp. 1136-1143
-
-
Aukrust, P.1
Ueland, T.2
Muller, F.3
Andreassen, A.K.4
Nordoy, I.5
Aas, H.6
Kjekshus, J.7
Simonsen, S.8
Fro, S.S.9
Gullestad, L.10
-
4
-
-
0033081764
-
Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
-
DOI 10.1016/S0002-9149(98)00872-8, PII S0002914998008728
-
Aukrust P, Ueland T, Lien E, et al. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1999;83:376-82. (Pubitemid 29066497)
-
(1999)
American Journal of Cardiology
, vol.83
, Issue.3
, pp. 376-382
-
-
Aukrust, P.1
Ueland, T.2
Lien, E.3
Bendtzen, K.4
Muller, F.5
Andreassen, A.K.6
Nordoy, I.7
Aass, H.8
Espevik, T.9
Simonsen, S.10
Froland, S.S.11
Gullestad, L.12
-
5
-
-
0025286817
-
Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
-
Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236-41. (Pubitemid 20225044)
-
(1990)
New England Journal of Medicine
, vol.323
, Issue.4
, pp. 236-241
-
-
Levine, B.1
Kalman, J.2
Mayer, L.3
Fillit, H.M.4
Packer, M.5
-
6
-
-
0037195727
-
Inflammatory mediators and the failing heart: Past, present, and the foreseeable future
-
DOI 10.1161/01.RES.0000043825.01705.1B
-
Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res. 2002;91:988-98. (Pubitemid 35416635)
-
(2002)
Circulation Research
, vol.91
, Issue.11
, pp. 988-998
-
-
Mann, D.L.1
-
8
-
-
85047692516
-
Signalling pathways of the TNF superfamily: A double-edged sword
-
DOI 10.1038/nril184
-
Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003;3:745-56. (Pubitemid 41070815)
-
(2003)
Nature Reviews Immunology
, vol.3
, Issue.9
, pp. 745-756
-
-
Aggarwal, B.B.1
-
9
-
-
0038320263
-
The signaling adaptors and pathways activated by TNF superfamily
-
DOI 10.1016/S1359-6101(03)00021-2
-
Dempsey PW, Doyle SE, He JQ, Cheng G. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev. 2003;14:193-209. (Pubitemid 36693141)
-
(2003)
Cytokine and Growth Factor Reviews
, vol.14
, Issue.3-4
, pp. 193-209
-
-
Dempsey, P.W.1
Doyle, S.E.2
He, J.Q.3
Cheng, G.4
-
10
-
-
0036172127
-
Fas receptor signaling inhibits glycogen synthase kinase 3β and induces cardiac hypertrophy following pressure overload
-
DOI 10.1172/JCI200213779
-
Badorff C, Ruetten H, Mueller S, et al. Fas receptor signaling inhibits glycogen synthase kinase 3 beta and induces cardiac hypertrophy following pressure overload. J Clin Invest. 2002;109:373-81. (Pubitemid 34141811)
-
(2002)
Journal of Clinical Investigation
, vol.109
, Issue.3
, pp. 373-381
-
-
Badorff, C.1
Ruetten, H.2
Mueller, S.3
Stahmer, M.4
Gehring, D.5
Jung, F.6
Ihling, C.7
Zeiher, A.M.8
Dimmeler, S.9
-
11
-
-
0030996297
-
The receptor for the cytotoxic ligand TRAIL
-
DOI 10.1126/science.276.5309.111
-
Pan G, O'Rourke K, Chinnaiyan AM, et al. The receptor for the cytotoxic ligand TRAIL. Science. 1997;276:111-3. (Pubitemid 27161256)
-
(1997)
Science
, vol.276
, Issue.5309
, pp. 111-113
-
-
Pan, G.1
O'Rourke, K.2
Chinnaiyan, A.M.3
Gentz, R.4
Ebner, R.5
Ni, J.6
Dixit, V.M.7
-
12
-
-
0029670957
-
Tumor necrosis factoralpha and tumor necrosis factor receptors in the failing human heart
-
Torre-Amione G, Kapadia S, Lee J, et al. Tumor necrosis factoralpha and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93:704-11.
-
(1996)
Circulation
, vol.93
, pp. 704-711
-
-
Torre-Amione, G.1
Kapadia, S.2
Lee, J.3
-
13
-
-
21044452012
-
Dysregulated osteoprotegerin/RANK ligand/RANK axis in clinical and experimental heart failure
-
DOI 10.1161/01.CIR.0000165119.62099.14
-
Ueland T, Yndestad A, Oie E, et al. Dysregulated osteoprotegerin/ RANK ligand/RANK axis in clinical and experimental heart failure. Circulation. 2005;111:2461-8. (Pubitemid 40696134)
-
(2005)
Circulation
, vol.111
, Issue.19
, pp. 2461-2468
-
-
Ueland, T.1
Yndestad, A.2
Oie, E.3
Florholmen, G.4
Halvorsen, B.5
Froland, S.S.6
Simonsen, S.7
Christensen, G.8
Gullestad, L.9
Aukrust, P.10
-
14
-
-
0032933614
-
Tumor necrosis factor-α: A mediator of disease progression in the failing human heart
-
DOI 10.1378/chest.115.4.1170
-
Herrera-Garza EH, Stetson SJ, Cubillos-Garzon A, et al. Tumor necrosis factor-alpha: a mediator of disease progression in the failing human heart. Chest. 1999;115:1170-4. (Pubitemid 29193693)
-
(1999)
Chest
, vol.115
, Issue.4
, pp. 1170-1174
-
-
Herrera-Garza, E.H.1
Stetson, S.J.2
Cubillos-Garzon, A.3
Vooletich, M.T.4
Farmer, J.A.5
Torre-Amione, G.6
-
15
-
-
0037084504
-
All TRAFs are not created equal: Common and distinct molecular mechanisms of TRAF-mediated signal transduction
-
Chung JY, Park YC, Ye H, Wu H. All TRAFs are not created equal: common and distinct molecular mechanisms of TRAFmediated signal transduction. J Cell Sci. 2002;115:679-88. (Pubitemid 34196328)
-
(2002)
Journal of Cell Science
, vol.115
, Issue.4
, pp. 679-688
-
-
Chung, J.Y.1
Park, Y.C.2
Ye, H.3
Wu, H.4
-
16
-
-
0642283970
-
Regulation of proliferation, survival and apoptosis by members of the TNF superfamily
-
DOI 10.1016/S0006-2952(03)00490-8, PII S0006295203004908
-
Gaur U, Aggarwal BB. Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol. 2003;66:1403-8. (Pubitemid 38373326)
-
(2003)
Biochemical Pharmacology
, vol.66
, Issue.8
, pp. 1403-1408
-
-
Gaur, U.1
Aggarwal, B.B.2
-
17
-
-
2342464085
-
The two NF-κB activation pathways and their role in innate and adaptive immunity
-
DOI 10.1016/j.it.2004.03.008, PII S1471490604001000
-
Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 2004;25:280-8. (Pubitemid 38610351)
-
(2004)
Trends in Immunology
, vol.25
, Issue.6
, pp. 280-288
-
-
Bonizzi, G.1
Karin, M.2
-
18
-
-
77149136451
-
Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile
-
Lutgens E, Lievens D, Beckers L, et al. Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. J Exp Med. 2010;207:391-404.
-
(2010)
J Exp Med
, vol.207
, pp. 391-404
-
-
Lutgens, E.1
Lievens, D.2
Beckers, L.3
-
19
-
-
0030970922
-
Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure
-
DOI 10.1016/S0735-1097(97)00055-7, PII S0735109797000557
-
Nishigaki K, Minatoguchi S, Seishima M, et al. Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. J Am Coll Cardiol. 1997;29:1214-20. (Pubitemid 27201937)
-
(1997)
Journal of the American College of Cardiology
, vol.29
, Issue.6
, pp. 1214-1220
-
-
Nishigaki, K.1
Minatoguchi, S.2
Seishima, M.3
Asano, K.4
Noda, T.5
Yasuda, N.6
Sano, H.7
Kumada, H.8
Takemura, M.9
Noma, A.10
Tanaka, T.11
Watanabe, S.12
Fujiwara, H.13
-
20
-
-
0033562721
-
Elevated circulating levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure
-
DOI 10.1016/S0002-9149(99)00133-2, PII S0002914999001332
-
Yamaguchi S, Yamaoka M, Okuyama M et al.: Elevated circulating levels and cardiac secretion of soluble Fas ligand in patients with congestive heart failure. Am J Cardiol. 1999;83:1500-1503, A8. (Pubitemid 29228352)
-
(1999)
American Journal of Cardiology
, vol.83
, Issue.10
, pp. 1500-1503
-
-
Yamaguchi, S.1
Yamaoka, M.2
Okuyama, M.3
Nitoube, J.4
Fukui, A.5
Shirakabe, M.6
Shirakawa, K.7
Nakamura, N.8
Tomoike, H.9
-
21
-
-
0036216193
-
Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure
-
Yndestad A, Damas JK, Geir EH, et al. Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure. Cardiovasc Res. 2002;54:175-82.
-
(2002)
Cardiovasc Res
, vol.54
, pp. 175-182
-
-
Yndestad, A.1
Damas, J.K.2
Geir, E.H.3
-
22
-
-
27844497509
-
TNF-related apoptosis-inducing ligand and its decoy receptor osteoprotegerin in nonischemic dilated cardiomyopathy
-
DOI 10.1016/j.bbrc.2005.10.136, PII S0006291X05024344
-
Schoppet M, Ruppert V, Hofbauer LC, et al. TNF-related apoptosis-inducing ligand and its decoy receptor osteoprotegerin in nonischemic dilated cardiomyopathy. Biochem Biophys Res Commun. 2005;338:1745-50. (Pubitemid 41643085)
-
(2005)
Biochemical and Biophysical Research Communications
, vol.338
, Issue.4
, pp. 1745-1750
-
-
Schoppet, M.1
Ruppert, V.2
Hofbauer, L.C.3
Henser, S.4
Al-Fakhri, N.5
Christ, M.6
Pankuweit, S.7
Maisch, B.8
-
23
-
-
17844408577
-
Soluble CD40 ligand in acute and chronic heart failure
-
DOI 10.1093/eurheartj/ehi132
-
Ueland T, Aukrust P, Yndestad A, et al. Soluble CD40 ligand in acute and chronic heart failure. Eur Heart J. 2005;26:1101-7. (Pubitemid 40839911)
-
(2005)
European Heart Journal
, vol.26
, Issue.11
, pp. 1101-1107
-
-
Ueland, T.1
Aukrust, P.2
Yndestad, A.3
Otterdal, K.4
Froland, S.S.5
Dickstein, K.6
Kjekshus, J.7
Gullestad, L.8
Damas, J.K.9
-
24
-
-
0034702911
-
Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia
-
Jeremias I, Kupatt C, Martin-Villalba A, et al. Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia. Circulation. 2000;102:915-20.
-
(2000)
Circulation
, vol.102
, pp. 915-920
-
-
Jeremias, I.1
Kupatt, C.2
Martin-Villalba, A.3
-
25
-
-
0031725655
-
The characterization of murine BCMA gene defines it as a new member of the tumor necrosis factor receptor superfamily
-
DOI 10.1093/intimm/10.11.1693
-
Madry C, Laabi Y, Callebaut I, et al. The characterization of murine BCMA gene defines it as a newmember of the tumor necrosis factor receptor superfamily. Int Immunol. 1998;10:1693-702. (Pubitemid 28502383)
-
(1998)
International Immunology
, vol.10
, Issue.11
, pp. 1693-1702
-
-
Madry, C.1
Laabi, Y.2
Callebaut, I.3
Roussel, J.4
Hatzoglou, A.5
Le Coniat, M.6
Mornon, J.-P.7
Berger, R.8
Tsapis, A.9
-
26
-
-
0030984895
-
A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation
-
DOI 10.1074/jbc.272.22.14272
-
Kwon BS, Tan KB, Ni J, et al. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem. 1997;272:14272-6. (Pubitemid 27232840)
-
(1997)
Journal of Biological Chemistry
, vol.272
, Issue.22
, pp. 14272-14276
-
-
Kwon, B.S.1
Tan, K.B.2
Ni, J.3
Kwi-Ok-Oh4
Lee, Z.H.5
Kim, K.K.6
Kim, Y.-J.7
Wang, S.8
Gentz, R.9
Yu, G.-L.10
Harrop, J.11
Lyn, S.D.12
Silverman, C.13
Porter, T.G.14
Truneh, A.15
Young, P.R.16
-
27
-
-
0030770614
-
Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL
-
DOI 10.1074/jbc.272.41.25417
-
MacFarlane M, Ahmad M, Srinivasula SM, et al. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J Biol Chem. 1997;272:25417-20. (Pubitemid 27438841)
-
(1997)
Journal of Biological Chemistry
, vol.272
, Issue.41
, pp. 25417-25420
-
-
MacFarlane, M.1
Ahmad, M.2
Srinivasula, S.M.3
Fernandes-Alnemri, T.4
Cohen, G.M.5
Alnemri, E.S.6
-
28
-
-
0032489353
-
TRUNDD, a new member of thr TRAIL receptor family that antagonizes TRAIL signalling
-
DOI 10.1016/S0014-5793(98)00135-5, PII S0014579398001355
-
Pan G, Ni J, Yu G, et al. TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling. FEBS Lett. 1998;424:41-5. (Pubitemid 28130348)
-
(1998)
FEBS Letters
, vol.424
, Issue.1-2
, pp. 41-45
-
-
Pan, G.1
Ni, J.2
Yu, G.-L.3
Wei, Y.-F.4
Dixit, V.M.5
-
29
-
-
0030762815
-
An antagonist decoy receptor and a death domain-containing receptor for TRAIL
-
DOI 10.1126/science.277.5327.815
-
Pan G, Ni J, Wei YF, et al. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science. 1997;277:815-8. (Pubitemid 27366732)
-
(1997)
Science
, vol.277
, Issue.5327
, pp. 815-818
-
-
Pan, G.1
Ni, J.2
Wei, Y.-F.3
Yu, G.-I.4
Gentz, R.5
Dixit, V.M.6
-
30
-
-
4544265332
-
Duality of innate stress responses in cardiac injury, repair, and remodeling
-
DOI 10.1016/j.yjmcc.2004.05.028, PII S0022282804001701
-
Wilson EM, Diwan A, Spinale FG, Mann DL. Duality of innate stress responses in cardiac injury, repair, and remodeling. J Mol Cell Cardiol. 2004;37:801-11. (Pubitemid 39222072)
-
(2004)
Journal of Molecular and Cellular Cardiology
, vol.37
, Issue.4
, pp. 801-811
-
-
Wilson, E.M.1
Diwan, A.2
Spinale, F.G.3
Mann, D.L.4
-
31
-
-
0035957036
-
Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure
-
Bozkurt B, Torre-Amione G, Warren MS, et al. Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation. 2001;103:1044-7. (Pubitemid 32200174)
-
(2001)
Circulation
, vol.103
, Issue.8
, pp. 1044-1047
-
-
Bozkurt, B.1
Torre-Amione, G.2
Warren, M.S.3
Whitmore, J.4
Soran, O.Z.5
Feldman, A.M.6
Mann, D.L.7
-
32
-
-
0038755661
-
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure: Results of the anti-TNF therapy against congestive heart failure (ATTACH) trial
-
DOI 10.1161/01.CIR.0000077913.60364.D2
-
Chung ES, Packer M, Lo KH, et al. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation. 2003;107:3133-40. (Pubitemid 36793081)
-
(2003)
Circulation
, vol.107
, Issue.25
, pp. 3133-3140
-
-
Chung, E.S.1
Packer, M.2
Lo, K.H.3
Fasanmade, A.A.4
Willerson, J.T.5
-
33
-
-
11144355760
-
Targeted Anticytokine Therapy in Patients with Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)
-
DOI 10.1161/01.CIR.0000124490.27666.B2
-
Mann DL, McMurray JJ, Packer M, et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation. 2004;109:1594-602. (Pubitemid 38451714)
-
(2004)
Circulation
, vol.109
, Issue.13
, pp. 1594-1602
-
-
Mann, D.L.1
McMurray, J.J.V.2
Packer, M.3
Swedberg, K.4
Borer, J.S.5
Colucci, W.S.6
Djian, J.7
Drexler, H.8
Feldman, A.9
Kober, L.10
Krum, H.11
Liu, P.12
Nieminen, M.13
Tavazzi, L.14
Van Veldhuisen, D.J.15
Waldenstrom, A.16
Warren, M.17
Westheim, A.18
Zannad, F.19
Fleming, T.20
more..
-
34
-
-
64549091508
-
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology
-
Heymans S, Hirsch E, Anker SD, et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009;11:119-29.
-
(2009)
Eur J Heart Fail
, vol.11
, pp. 119-129
-
-
Heymans, S.1
Hirsch, E.2
Anker, S.D.3
-
35
-
-
0032746314
-
Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors
-
Darnay BG, Aggarwal BB. Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors. Ann Rheum Dis. 1999;58 Suppl 1:I2-I13.
-
(1999)
Ann Rheum Dis.
, vol.58
, Issue.SUPPL. 1
-
-
Darnay, B.G.1
Aggarwal, B.B.2
-
36
-
-
0038813632
-
Apoptosis in heart: Basic mechanisms and implications in cardiovascular diseases
-
DOI 10.1016/S1471-4914(03)00025-X
-
Kang PM, Izumo S. Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases. Trends Mol Med. 2003;9:177-82. (Pubitemid 36626707)
-
(2003)
Trends in Molecular Medicine
, vol.9
, Issue.4
, pp. 177-182
-
-
Kang, P.M.1
Izumo, S.2
-
37
-
-
11144307292
-
STRESS signaling pathways that modulate cardiac myocyte apoptosis
-
DOI 10.1016/j.yjmcc.2004.11.004, PII S0022282804003256
-
Baines CP, Molkentin JD. STRESS signaling pathways that modulate cardiac myocyte apoptosis. J Mol Cell Cardiol. 2005;38:47-62. (Pubitemid 40038651)
-
(2005)
Journal of Molecular and Cellular Cardiology
, vol.38
, Issue.1
, pp. 47-62
-
-
Baines, C.P.1
Molkentin, J.D.2
-
38
-
-
0037230940
-
Acute and chronic endothelial dysfunction: Implications for the development of heart failure
-
DOI 10.1023/A:1022151106019
-
Linke A, Recchia F, Zhang X, Hintze TH. Acute and chronic endothelial dysfunction: implications for the development of heart failure. Heart Fail Rev. 2003;8:87-97. (Pubitemid 36342292)
-
(2003)
Heart Failure Reviews
, vol.8
, Issue.1
, pp. 87-97
-
-
Linke, A.1
Recchia, F.2
Zhang, X.3
Hintze, T.H.4
-
39
-
-
0642342931
-
Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure
-
DOI 10.1016/S0008-6363(03)00362-6, PII S0008636303003626
-
Yndestad A, Holm AM, Muller F, et al. Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res. 2003;60:141-6. (Pubitemid 38373485)
-
(2003)
Cardiovascular Research
, vol.60
, Issue.1
, pp. 141-146
-
-
Yndestad, A.1
Holm, A.M.2
Muller, F.3
Simonsen, S.4
Froland, S.S.5
Gullestad, L.6
Aukrust, P.7
-
40
-
-
0034509413
-
Cytotoxic T lymphocytes are activated following myocardial infarction and can recognize and kill healthy myocytes in vitro
-
DOI 10.1006/jmcc.2000.1261
-
Varda-Bloom N, Leor J, Ohad DG, et al. Cytotoxic T lymphocytes are activated following myocardial infarction and can recognize and kill healthy myocytes in vitro. J Mol Cell Cardiol. 2000;32:2141-9. (Pubitemid 32039766)
-
(2000)
Journal of Molecular and Cellular Cardiology
, vol.32
, Issue.12
, pp. 2141-2149
-
-
Varda-Bloom, N.1
Leor, J.2
Ohad, D.G.3
Hasin, Y.4
Amar, M.5
Fixler, R.6
Battler, A.7
Eldar, M.8
Hasin, D.9
-
41
-
-
0037216823
-
Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes
-
DOI 10.1016/S0008-6363(02)00646-6, PII S0008636302006466
-
Nitobe J, Yamaguchi S, Okuyama M, et al. Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes. Cardiovasc Res. 2003;57:119-28. (Pubitemid 36009443)
-
(2003)
Cardiovascular Research
, vol.57
, Issue.1
, pp. 119-128
-
-
Nitobe, J.1
Yamaguchi, S.2
Okuyama, M.3
Nozaki, N.4
Sata, M.5
Miyamoto, T.6
Takeishi, Y.7
Kubota, I.8
Tomoike, H.9
-
42
-
-
0036273957
-
Hypoxia predisposes neonatal rat ventricular myocytes to apoptosis induced by activation of the Fas (CD95/Apo-1) receptor: Fas activation and apoptosis in hypoxic myocytes
-
DOI 10.1016/S0008-6363(02)00264-X, PII S000863630200264X
-
Yaniv G, Shilkrut M, Lotan R, et al. Hypoxia predisposes neonatal rat ventricular myocytes to apoptosis induced by activation of the Fas (CD95/Apo-1) receptor: Fas activation and apoptosis in hypoxic myocytes. Cardiovasc Res. 2002;54:611-23. (Pubitemid 34595420)
-
(2002)
Cardiovascular Research
, vol.54
, Issue.3
, pp. 611-623
-
-
Yaniv, G.1
Shilkrut, M.2
Lotan, R.3
Berke, G.4
Larisch, S.5
Binah, O.6
-
43
-
-
0038320035
-
Apo2L/TRAIL: Apoptosis signaling, biology, and potential for cancer therapy
-
DOI 10.1016/S1359-6101(03)00029-7
-
Almasan A, Ashkenazi A. Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev. 2003;14:337-48. (Pubitemid 36693152)
-
(2003)
Cytokine and Growth Factor Reviews
, vol.14
, Issue.3-4
, pp. 337-348
-
-
Almasan, A.1
Ashkenazi, A.2
-
44
-
-
0035992505
-
On the TRAIL to apoptosis
-
DOI 10.1016/S1359-6101(02)00006-0, PII S1359610102000060
-
Baetu TM, Hiscott J. On the TRAIL to apoptosis. Cytokine Growth Factor Rev. 2002;13:199-207. (Pubitemid 34693174)
-
(2002)
Cytokine and Growth Factor Reviews
, vol.13
, Issue.3
, pp. 199-207
-
-
Baetu, T.M.1
Hiscott, J.2
-
45
-
-
64549087652
-
Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: Role of nuclear factor-kappaB and inflammatory activation
-
This experimental study illustrates the complexity of the interplay between TNF-related molecules in HF by showing disparate and opposing effects by TNFR1 and TNFR2 on myocardial remodeling, hypertrophy, NF-κB activation, inflammation, and apoptosis
-
Hamid T, Gu Y, Ortines RV, et al. Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation. Circulation. 2009;119:1386-97. This experimental study illustrates the complexity of the interplay between TNF-related molecules in HF by showing disparate and opposing effects by TNFR1 and TNFR2 on myocardial remodeling, hypertrophy, NF-κB activation, inflammation, and apoptosis.
-
(2009)
Circulation
, vol.119
, pp. 1386-1397
-
-
Hamid, T.1
Gu, Y.2
Ortines, R.V.3
-
46
-
-
0035859841
-
Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor
-
Sivasubramanian N, Coker ML, Kurrelmeyer KM, et al. Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor. Circulation. 2001;104:826-31. (Pubitemid 32762683)
-
(2001)
Circulation
, vol.104
, Issue.7
, pp. 826-831
-
-
Sivasubramanian, N.1
Coker, M.L.2
Kurrelmeyer, K.M.3
MacLellan, W.R.4
DeMayo, F.J.5
Spinale, F.G.6
Mann, D.L.7
-
47
-
-
12944312764
-
Proinflammatory consequences of transgenic Fas ligand expression in the heart
-
Nelson DP, Setser E, Hall DG, et al. Proinflammatory consequences of transgenic fas ligand expression in the heart. J Clin Invest. 2000;105:1199-208. (Pubitemid 30266072)
-
(2000)
Journal of Clinical Investigation
, vol.105
, Issue.9
, pp. 1199-1208
-
-
Nelson, D.P.1
Setser, E.2
Hall, D.G.3
Schwartz, S.M.4
Hewitt, T.5
Klevitsky, R.6
Osinska, H.7
Bellgrau, D.8
Duke, R.C.9
Robbins, J.10
-
48
-
-
0036084756
-
MMP inhibition modulates TNF-α transgenic mouse phenotype early in the development of heart failure
-
51-3
-
Li YY, Kadokami T, Wang P, et al. MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure. Am J Physiol Heart Circ Physiol. 2002;282:H983-9. (Pubitemid 34654937)
-
(2002)
American Journal of Physiology - Heart and Circulatory Physiology
, vol.282
, Issue.3
-
-
Li, Y.Y.1
Kadokami, T.2
Wang, P.3
McTiernan, C.F.4
Feldman, A.M.5
-
49
-
-
0035572244
-
Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases
-
Lee WH, Kim SH, Lee Y, et al. Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arterioscler Thromb Vasc Biol. 2001;21:2004-10. (Pubitemid 34219754)
-
(2001)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.21
, Issue.12
, pp. 2004-2010
-
-
Lee, W.-H.1
Kim, S.-H.2
Lee, Y.3
Byung, B.L.4
Kwon, B.5
Song, H.6
Kwon, B.S.7
Park, J.-E.8
-
50
-
-
0344699318
-
T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: Implications for tubule formation
-
Mach F, Schonbeck U, Fabunmi RP, et al. T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40Ldependent mechanism: implications for tubule formation. Am J Pathol. 1999;154:229-38. (Pubitemid 29031630)
-
(1999)
American Journal of Pathology
, vol.154
, Issue.1
, pp. 229-238
-
-
Mach, F.1
Schonbeck, U.2
Fabunmi, R.P.3
Murphy, C.4
Atkinson, E.5
Bonnefoy, J.-Y.6
Graber, P.7
Libby, P.8
-
51
-
-
0037311527
-
Tumor necrosis factor-related apoptosis-inducing ligand enhances collagen production by human lung fibroblasts
-
DOI 10.1165/rcmb.2002-0140OC
-
Yurovsky VV. Tumor necrosis factor-related apoptosis-inducing ligand enhances collagen production by human lung fibroblasts. Am J Respir Cell Mol Biol. 2003;28:225-31. (Pubitemid 36169652)
-
(2003)
American Journal of Respiratory Cell and Molecular Biology
, vol.28
, Issue.2
, pp. 225-231
-
-
Yurovsky, V.V.1
-
52
-
-
80053124249
-
TNFalpha increases cardiac fibroblast lysyl oxidase expression through TGF-beta and PI3Kinase signaling pathways
-
This study illustrates the complex role of TNF-related molecules in ECM remodeling, promoting both matrix degradation and enhanced collagen synthesis partly depending on co-stimuli and concentration of TNF-related molecule
-
Voloshenyuk TG, Hart AD, Khoutorova E, Gardner JD. TNFalpha increases cardiac fibroblast lysyl oxidase expression through TGF-beta and PI3Kinase signaling pathways. Biochem Biophys Res Commun. 2011;413:370-5. This study illustrates the complex role of TNF-related molecules in ECM remodeling, promoting both matrix degradation and enhanced collagen synthesis partly depending on co-stimuli and concentration of TNF-related molecule.
-
(2011)
Biochem Biophys Res Commun.
, vol.413
, pp. 370-375
-
-
Voloshenyuk, T.G.1
Hart, A.D.2
Khoutorova, E.3
Gardner, J.D.4
-
53
-
-
8144227919
-
Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction
-
DOI 10.1016/j.jacc.2004.06.076, PII S073510970401705X
-
Ueland T, Jemtland R, Godang K, et al. Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction. J Am Coll Cardiol. 2004;44:1970-6. (Pubitemid 39473280)
-
(2004)
Journal of the American College of Cardiology
, vol.44
, Issue.10
, pp. 1970-1976
-
-
Ueland, T.1
Jemtland, R.2
Godang, K.3
Kjekshus, J.4
Hognestad, A.5
Omland, T.6
Squire, I.B.7
Gullestad, L.8
Bollerslev, J.9
Dickstein, K.10
Aukrust, P.11
-
54
-
-
45849111384
-
Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease
-
Liu W, Feng W, Wang F, et al. Osteoprotegerin/RANK/RANKL axis in cardiac remodeling due to immuno-inflammatory myocardial disease. Exp Mol Pathol. 2008;84:213-7.
-
(2008)
Exp Mol Pathol
, vol.84
, pp. 213-217
-
-
Liu, W.1
Feng, W.2
Wang, F.3
-
55
-
-
80054034731
-
Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosis
-
Ueland T, Aukrust P, Dahl CP, et al. Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosis. J Intern Med. 2011;270:452-60.
-
(2011)
J Intern Med
, vol.270
, pp. 452-460
-
-
Ueland, T.1
Aukrust, P.2
Dahl, C.P.3
-
56
-
-
0037644721
-
Biology of the TRANCE axis
-
DOI 10.1016/S1359-6101(03)00027-3
-
Walsh MC, Choi Y. Biology of the TRANCE axis. Cytokine Growth Factor Rev. 2003;14:251-63. (Pubitemid 36693145)
-
(2003)
Cytokine and Growth Factor Reviews
, vol.14
, Issue.3-4
, pp. 251-263
-
-
Walsh, M.C.1
Choi, Y.2
-
57
-
-
70350575289
-
IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenolinduced heart failure
-
Feng W, Li W, Liu W, et al. IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenolinduced heart failure. Exp Mol Pathol. 2009;87:212-8.
-
(2009)
Exp Mol Pathol
, vol.87
, pp. 212-218
-
-
Feng, W.1
Li, W.2
Liu, W.3
-
58
-
-
33646441388
-
Enhanced T-cell expression of RANK ligand in acute coronary syndrome: Possible role in plaque destabilization
-
DOI 10.1161/01.ATV.0000204334.48195.6a, PII 0004360520060400000028
-
Sandberg WJ, Yndestad A, Oie E, et al. Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization. Arterioscler Thromb Vasc Biol. 2006;26:857-63. (Pubitemid 43732163)
-
(2006)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.26
, Issue.4
, pp. 857-863
-
-
Sandberg, W.J.1
Yndestad, A.2
Oie, E.3
Smith, C.4
Ueland, T.5
Ovchinnikova, O.6
Robertson, A.-K.L.7
Muller, F.8
Semb, A.G.9
Scholz, H.10
Andreassen, A.K.11
Gullestad, L.12
Damas, J.K.13
Froland, S.S.14
Hansson, G.K.15
Halvorsen, B.16
Aukrust, P.17
-
59
-
-
44949114393
-
Serum levels of the osteoprotegerin, receptor activator of nuclear factor κ-B ligand, metalloproteinase-1 (MMP-1) and tissue inhibitors of MMP-1 levels are increased in men 6 months after acute myocardial infarction
-
DOI 10.1515/CCLM.2008.091
-
Halapas A, Zacharoulis A, Theocharis S, et al. Serum levels of the osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, metalloproteinase-1 (MMP-1) and tissue inhibitors of MMP-1 levels are increased in men 6 months after acute myocardial infarction. Clin Chem Lab Med. 2008;46:510-6. (Pubitemid 351820350)
-
(2008)
Clinical Chemistry and Laboratory Medicine
, vol.46
, Issue.4
, pp. 510-516
-
-
Halapas, A.1
Zacharoulis, A.2
Theocharis, S.3
Karavidas, A.4
Korres, D.5
Papadopoulos, K.6
Katopodis, H.7
Stavropoulou, A.8
Lembessis, P.9
Xiromeritis, C.10
Zacharoulis, A.11
Koutsilieris, M.12
-
60
-
-
64849108593
-
Prognostic value of apoptosis markers in advanced heart failure patients
-
This study describes discrepant effects of soluble TNF-related markers of apoptosis on the prognosis of advanced HF and indicates that sTRAIL could be of interest as a therapeutic agent. It also illustrates the importance of fully understanding pathophysiological processes before selecting specific pathways as therapeutic target
-
Niessner A, Hohensinner PJ, Rychli K, et al. Prognostic value of apoptosis markers in advanced heart failure patients. Eur Heart J. 2009;30:789-96. This study describes discrepant effects of soluble TNF-related markers of apoptosis on the prognosis of advanced HF and indicates that sTRAIL could be of interest as a therapeutic agent. It also illustrates the importance of fully understanding pathophysiological processes before selecting specific pathways as therapeutic target.
-
(2009)
Eur Heart J.
, vol.30
, pp. 789-796
-
-
Niessner, A.1
Hohensinner, P.J.2
Rychli, K.3
-
61
-
-
77952427166
-
An imbalanced OPG/ TRAIL ratio is associated to severe acute myocardial infarction
-
Secchiero P, Corallini F, Beltrami AP, et al. An imbalanced OPG/ TRAIL ratio is associated to severe acute myocardial infarction. Atherosclerosis. 2010;210:274-7.
-
(2010)
Atherosclerosis
, vol.210
, pp. 274-277
-
-
Secchiero, P.1
Corallini, F.2
Beltrami, A.P.3
-
62
-
-
77950605368
-
TNF-alpha modulates the migratory response of mesenchymal stem cells to TRAIL
-
Corallini F, Secchiero P, Beltrami AP, et al. TNF-alpha modulates the migratory response of mesenchymal stem cells to TRAIL. Cell Mol Life Sci. 2010;67:1307-14.
-
(2010)
Cell Mol Life Sci
, vol.67
, pp. 1307-1314
-
-
Corallini, F.1
Secchiero, P.2
Beltrami, A.P.3
-
63
-
-
77955456565
-
Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial
-
Roysland R, Masson S, Omland T, et al. Prognostic value of osteoprotegerin in chronic heart failure: The GISSI-HF trial. Am Heart J. 2010;160:286-93.
-
(2010)
Am Heart J
, vol.160
, pp. 286-293
-
-
Roysland, R.1
Masson, S.2
Omland, T.3
-
64
-
-
79955929820
-
Osteoprotegerin predicts progression of chronic heart failure: Results from CORONA
-
Ueland T, Dahl CP, Kjekshus J, et al. Osteoprotegerin predicts progression of chronic heart failure: results from CORONA. Circ Heart Fail. 2011;4:145-52.
-
(2011)
Circ Heart Fail
, vol.4
, pp. 145-152
-
-
Ueland, T.1
Dahl, C.P.2
Kjekshus, J.3
-
65
-
-
0035139584
-
The effect of a single dose of osteoprotegerin in postmenopausal women
-
Bekker PJ, Holloway D, Nakanishi A, et al. The effect of a single dose of osteoprotegerin in postmenopausal women. J Bone Miner Res. 2001;16:348-60. (Pubitemid 32105416)
-
(2001)
Journal of Bone and Mineral Research
, vol.16
, Issue.2
, pp. 348-360
-
-
Bekker, P.J.1
Holloway, D.2
Nakanishi, A.3
Arrighi, M.4
Leese, P.T.5
Dunstan, C.R.6
-
67
-
-
43549099569
-
Biomarkers in heart failure
-
Braunwald E. Biomarkers in heart failure. N Engl J Med. 2008;358:2148-59.
-
(2008)
N Engl J Med
, vol.358
, pp. 2148-2159
-
-
Braunwald, E.1
-
68
-
-
33847327365
-
Benchmarks for the assessment of novel cardiovascular biomarkers
-
DOI 10.1161/CIRCULATIONAHA.106.683110, PII 0000301720070227000004
-
Morrow DA, de Lemos JA. Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation. 2007;115:949-52. (Pubitemid 46328287)
-
(2007)
Circulation
, vol.115
, Issue.8
, pp. 949-952
-
-
Morrow, D.A.1
De Lemos, J.A.2
-
69
-
-
0034687595
-
Plasma cytokine parameters and mortality in patients with chronic heart failure
-
Rauchhaus M, Doehner W, Francis DP, et al. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation. 2000;102:3060-7.
-
(2000)
Circulation
, vol.102
, pp. 3060-3067
-
-
Rauchhaus, M.1
Doehner, W.2
Francis, D.P.3
-
70
-
-
0342424731
-
Prognostic value of serum cytokines in patients with congestive heart failure
-
DOI 10.1016/S1053-2498(00)00083-8, PII S1053249800000838
-
Orus J, Roig E, Perez-Villa F, et al. Prognostic value of serum cytokines in patients with congestive heart failure. J Heart Lung Transplant. 2000;19:419-25. (Pubitemid 30249079)
-
(2000)
Journal of Heart and Lung Transplantation
, vol.19
, Issue.5
, pp. 419-425
-
-
Orus, J.1
Roig, E.2
Perez-Villa, F.3
Pare, C.4
Azqueta, M.5
Filella, X.6
Heras, M.7
Sanz, G.8
-
71
-
-
0035942264
-
Cytokines and cytokine receptors in advanced heart failure: An analysis of the cytokine database from the Vesnarinone Trial (VEST)
-
Deswal A, Petersen NJ, Feldman AM, et al. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation. 2001;103:2055-9. (Pubitemid 32373007)
-
(2001)
Circulation
, vol.103
, Issue.16
, pp. 2055-2059
-
-
Deswal, A.1
Petersen, N.J.2
Feldman, A.M.3
Young, J.B.4
White, B.G.5
Mann, D.L.6
-
72
-
-
41449114378
-
Prognostic role of proand anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure
-
Miettinen KH, Lassus J, Harjola VP, et al. Prognostic role of proand anti-inflammatory cytokines and their polymorphisms in acute decompensated heart failure. Eur J Heart Fail. 2008;10:396-403.
-
(2008)
Eur J Heart Fail
, vol.10
, pp. 396-403
-
-
Miettinen, K.H.1
Lassus, J.2
Harjola, V.P.3
-
73
-
-
20044381106
-
Tumor necrosis factor-α receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: The cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study
-
DOI 10.1161/01.CIR.0000155614.35441.69
-
Valgimigli M, Ceconi C, Malagutti P, et al. Tumor necrosis factoralpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study. Circulation. 2005;111:863-70. (Pubitemid 40279887)
-
(2005)
Circulation
, vol.111
, Issue.7
, pp. 863-870
-
-
Valgimigli, M.1
Ceconi, C.2
Malagutti, P.3
Merli, E.4
Soukhomovskaia, O.5
Francolini, G.6
Cicchitelli, G.7
Olivares, A.8
Parrinello, G.9
Percoco, G.10
Guardigli, G.11
Mele, D.12
Pirani, R.13
Ferrari, R.14
-
74
-
-
14144252954
-
Tumour necrosis factor α and troponin T as predictors of poor prognosis in patients with stable heart failure
-
Rodriguez-Reyna TS, Arrieta O, Castillo-Martinez L, et al. Tumour Necrosis Factor alpha and Troponin Tas predictors of poor prognosis in patients with stable heart failure. Clin Invest Med. 2005;28:23-9. (Pubitemid 40283422)
-
(2005)
Clinical and Investigative Medicine
, vol.28
, Issue.1
, pp. 23-29
-
-
Rodriguez-Reyna, T.S.1
Arrieta, O.2
Castillo-Martinez, L.3
Orea-Tejeda, A.4
Guevara, P.5
Rebollar, V.6
Granados, J.7
-
75
-
-
0037012406
-
Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: Role of fat and carbohydrate meals
-
DOI 10.1016/S0735-1097(02)01741-2, PII S0735109702017412
-
Nappo F, Esposito K, Cioffi M, et al. Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals. J Am Coll Cardiol. 2002;39:1145-50. (Pubitemid 34267417)
-
(2002)
Journal of the American College of Cardiology
, vol.39
, Issue.7
, pp. 1145-1150
-
-
Nappo, F.1
Esposito, K.2
Cioffi, M.3
Giugliano, G.4
Molinari, A.M.5
Paolisso, G.6
Marfella, R.7
Giugliano, D.8
-
77
-
-
70350673929
-
Decreased soluble TWEAK levels predict an adverse prognosis in patients with chronic stable heart failure
-
Chorianopoulos E, Rosenberg M, Zugck C, et al. Decreased soluble TWEAK levels predict an adverse prognosis in patients with chronic stable heart failure. Eur J Heart Fail. 2009;11:1050-6.
-
(2009)
Eur J Heart Fail
, vol.11
, pp. 1050-1056
-
-
Chorianopoulos, E.1
Rosenberg, M.2
Zugck, C.3
-
78
-
-
78649736865
-
Differences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in advanced ischemic and non-ischemic heart failure
-
Richter B, Rychli K, Hohensinner PJ, et al. Differences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in advanced ischemic and non-ischemic heart failure. Atherosclerosis. 2010;213:545-8.
-
(2010)
Atherosclerosis
, vol.213
, pp. 545-548
-
-
Richter, B.1
Rychli, K.2
Hohensinner, P.J.3
-
79
-
-
0029117828
-
Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure
-
Ferrari R, Bachetti T, Confortini R, et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation. 1995;92:1479-86.
-
(1995)
Circulation
, vol.92
, pp. 1479-1486
-
-
Ferrari, R.1
Bachetti, T.2
Confortini, R.3
-
80
-
-
28244446690
-
Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients
-
DOI 10.1016/j.jacc.2005.08.039, PII S0735109705021935
-
Ueland T, Kjekshus J, Froland SS, et al. Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patients. J Am Coll Cardiol. 2005;46:2018-21. (Pubitemid 41713585)
-
(2005)
Journal of the American College of Cardiology
, vol.46
, Issue.11
, pp. 2018-2021
-
-
Ueland, T.1
Kjekshus, J.2
Froland, S.S.3
Omland, T.4
Squire, I.B.5
Gullestad, L.6
Dickstein, K.7
Aukrust, P.8
-
81
-
-
56749173769
-
The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: A systematic literature review
-
Nybo M, Rasmussen LM. The capability of plasma osteoprotegerin as a predictor of cardiovascular disease: a systematic literature review. Eur J Endocrinol. 2008;159:603-8.
-
(2008)
Eur J Endocrinol
, vol.159
, pp. 603-608
-
-
Nybo, M.1
Rasmussen, L.M.2
-
82
-
-
34249325167
-
Plasma osteoprotegerin levels in the general population: Relation to indices of left ventricular structure and function
-
DOI 10.1161/HYPERTENSIONAHA.107.087742, PII 0000426820070600000036
-
Omland T, Drazner MH, Ueland T, et al. Plasma osteoprotegerin levels in the general population: relation to indices of left ventricular structure and function. Hypertension. 2007;49:1392-8. (Pubitemid 46809385)
-
(2007)
Hypertension
, vol.49
, Issue.6
, pp. 1392-1398
-
-
Omland, T.1
Drazner, M.H.2
Ueland, T.3
Abedin, M.4
Murphy, S.A.5
Aukrust, P.6
De Lemos, J.A.7
-
83
-
-
38849186660
-
Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes
-
DOI 10.1016/j.jacc.2007.09.058, PII S0735109707036765
-
Omland T, Ueland T, Jansson AM, et al. Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes. J Am Coll Cardiol. 2008;51:627-33. (Pubitemid 351193104)
-
(2008)
Journal of the American College of Cardiology
, vol.51
, Issue.6
, pp. 627-633
-
-
Omland, T.1
Ueland, T.2
Jansson, A.M.3
Persson, A.4
Karlsson, T.5
Smith, C.6
Herlitz, J.7
Aukrust, P.8
Hartford, M.9
Caidahl, K.10
-
84
-
-
8744309820
-
Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state
-
DOI 10.1111/j.1365-2362.2004.01414.x
-
Jellema A, Plat J, Mensink RP. Weight reduction, but not a moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 antigen in obese men during the fasting and postprandial state. Eur J Clin Invest. 2004;34:766-73. (Pubitemid 39524302)
-
(2004)
European Journal of Clinical Investigation
, vol.34
, Issue.11
, pp. 766-773
-
-
Jellema, A.1
Plat, J.2
Mensink, R.P.3
-
85
-
-
2442457425
-
Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers
-
DOI 10.1016/j.bbi.2003.12.009, PII S0889159104000194
-
Haack M, Pollmacher T, Mullington JM. Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers. Brain Behav Immun. 2004;18:361-7. (Pubitemid 38648833)
-
(2004)
Brain, Behavior, and Immunity
, vol.18
, Issue.4
, pp. 361-367
-
-
Haack, M.1
Pollmacher, T.2
Mullington, J.M.3
-
86
-
-
33646539111
-
The tumor necrosis factor superfamily in heart failure
-
Ueland T, Aukrust P, Damas JK, et al. The tumor necrosis factor superfamily in heart failure. Future Cardiol. 2006;2:101-11.
-
(2006)
Future Cardiol
, vol.2
, pp. 101-111
-
-
Ueland, T.1
Aukrust, P.2
Damas, J.K.3
|